Fig. 2
From: Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans
Agar drug diffusion susceptibility assay of Candida albicans SN250. Plates were treated with various concentrations of drugs after spreading of 200 μl of liquid Candida culture and left to incubate overnight in either 25 or 37 °C. The middle of the plate served as the negative control, DMSO. Dilutions that failed to exhibit discernable inhibition after one plates were further diluted a second time. The size of the zone of inhibition on each image is shown with the same scale (mm), with standard deviation values are shown in Additional file 1 Table S2